Posts

STAT+: EPA fines Roche’s Genentech unit for hazardous waste violations

STAT+: EPA fines Roche’s Genentech unit for hazardous w...

Aug 11, 2023

The EPA fined Genentech more than $158,000 for hazardous waste violations at a f...

STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’ that underpays out-of-network medical claims

STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’...

Aug 11, 2023

AdventHealth has sued MultiPlan, alleging the company has worked with health ins...

STAT+: What to know about concerns raised by compounded versions of Novo Nordisk’s Wegovy

STAT+: What to know about concerns raised by compounded...

Aug 11, 2023

Here's what you need to know regarding the concerns raised about compounded vers...

Listen: Your guide to Wegovy’s blockbuster heart study

Aug 11, 2023

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And...

Covid took a toll on heart health — and doctors are still grappling with how to help

Covid took a toll on heart health — and doctors are sti...

Aug 11, 2023

“We’re about to exit this pandemic as even a sicker nation” because of virus-rel...

STAT+: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer

STAT+: A yogurt drink instead of a colonoscopy? Study u...

Aug 11, 2023

Using yogurt to replace a colonoscopy may sound far-fetched, but scientists just...

Pharma budget tightening trickles down to Doximity

Pharma budget tightening trickles down to Doximity

Aug 11, 2023

In the latest edition of STAT's Health Tech newsletter: pharma budget tightening...

STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

STAT+: Pharmalittle: Genentech weighs delaying cancer t...

Aug 11, 2023

CEO says Medicare negotiation could encourage Genentech to slow-walk ovarian can...

STAT+: Anavex, maker of rare disease drug, keeps shifting the goalposts in its clinical trials

STAT+: Anavex, maker of rare disease drug, keeps shifti...

Aug 11, 2023

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial...

STAT+: Novo acquires Inversago for up to $1 billion, spotlighting troubled weight loss approach

STAT+: Novo acquires Inversago for up to $1 billion, sp...

Aug 11, 2023

Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a sma...

STAT+: Where are patients getting their prescriptions for GLP-1 drugs like Wegovy and Ozempic?

STAT+: Where are patients getting their prescriptions f...

Aug 11, 2023

A new analysis suggests telehealth companies could account for nearly half of al...

Malaria vaccine candidate appears safe and produces promising immune response in a cohort of Tanzanian infants

Malaria vaccine candidate appears safe and produces pro...

Aug 11, 2023

An experimental malaria vaccine appears safe and promotes an immune response in ...

Using the body’s “invisible scalpel” to remove brain cancer

Using the body’s “invisible scalpel” to remove brain ca...

Aug 11, 2023

LA JOLLA (August 11, 2023)—Glioblastoma, the most common and deadly form of brai...

Researchers identify 135 new melanin genes responsible for pigmentation

Researchers identify 135 new melanin genes responsible ...

Aug 11, 2023

The skin, hair and eye color of more than eight billion humans is determined by ...

University of Chicago scientists invent smallest known way to guide light

University of Chicago scientists invent smallest known ...

Aug 11, 2023

Directing light from place to the place is the backbone of our modern world. Ben...

Holger Hanselka takes office as president of Fraunhofer-Gesellschaft

Holger Hanselka takes office as president of Fraunhofer...

Aug 11, 2023

“This farewell is far from being easy for me. After ten years of intense joint w...